Perrigo Revenue 2006-2019 | PRGO

Perrigo annual/quarterly revenue history and growth rate from 2006 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Perrigo revenue for the quarter ending September 30, 2019 was $1.191B, a 5.12% increase year-over-year.
  • Perrigo revenue for the twelve months ending September 30, 2019 was $4.710B, a 2.28% decline year-over-year.
  • Perrigo annual revenue for 2018 was $4.732B, a 4.34% decline from 2017.
  • Perrigo annual revenue for 2017 was $4.946B, a 6.33% decline from 2016.
  • Perrigo annual revenue for 2016 was $5.281B, a 100.62% increase from 2015.
Perrigo Annual Revenue
(Millions of US $)
2018 $4,732
2017 $4,946
2016 $5,281
2015 $2,632
2015 $4,227
2014 $3,914
2013 $3,540
2012 $3,173
2011 $2,755
2010 $2,268
2009 $2,006
2008 $1,730
2007 $1,368
2006 $1,367
2005 $1,024
Perrigo Quarterly Revenue
(Millions of US $)
Q3 2019 $1,191
Q2 2019 $1,149
Q1 2019 $1,175
Q4 2018 $1,195
Q3 2018 $1,133
Q2 2018 $1,186
Q1 2018 $1,217
Q4 2017 $1,283
Q3 2017 $1,231
Q2 2017 $1,238
Q1 2017 $1,194
Q4 2016 $1,331
Q3 2016 $1,262
Q2 2016 $1,341
Q1 2016 $1,347
Q4 2015 $-1,023
Q3 2015 $1,273
Q2 2015
Q1 2015 $967
Q4 2014 $1,072
Q3 2014 $952
Q2 2014
Q1 2014 $1,004
Q4 2013 $979
Q3 2013 $933
Q2 2013
Q1 2013 $920
Q4 2012 $883
Q3 2012 $770
Q2 2012
Q1 2012 $778
Q4 2011 $838
Q3 2011 $725
Q2 2011
Q1 2011 $692
Q4 2010 $718
Q3 2010 $641
Q2 2010
Q1 2010 $538
Q4 2009 $582
Q3 2009 $528
Q2 2009
Q1 2009 $506
Q4 2008 $537
Q3 2008 $456
Q2 2008
Q1 2008 $481
Q4 2007 $435
Q3 2007 $383
Q2 2007
Q1 2007 $362
Q4 2006 $371
Q3 2006 $340
Q2 2006
Q1 2006 $332
Q4 2005
Q3 2005 $320
Q2 2005
Q1 2005 $220
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $7.324B $4.732B
Perrigo Company plc develops, manufactures and distributes healthcare products. The company operates primarily in four segments: Consumer Healthcare, Nutritionals, Rx Pharmaceutical and Active Pharmaceutical Ingredients. It also provides animal health products. The company operates primarily in the United States, the United Kingdom, Mexico, Israel, Australia, Canada, China and Latin America. Perrigo Company plc formerly known as Perrigo Company is headquartered in Ireland.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $150.160B 27.39
Medtronic (MDT) Ireland $149.747B 20.69
Stryker (SYK) United States $74.065B 24.90
Boston Scientific (BSX) United States $61.077B 28.83
Baxter (BAX) United States $42.381B 25.70
Essilor Luxottica (ESLOY) France $33.712B 0.00
Zimmer Biomet Holdings (ZBH) United States $30.238B 18.97
Terumo (TRUMY) Japan $26.963B 33.65
Lonza Group Ag (LZAGY) Switzerland $25.222B 0.00
Coloplast (CLPBY) Denmark $24.840B 38.33
ResMed (RMD) United States $21.637B 39.92
Smith & Nephew SNATS (SNN) United Kingdom $19.607B 0.00
Sunny Optical Technology (SNPTF) China $19.217B 0.00
Insulet (PODD) United States $11.140B 529.97
Bio-Rad Laboratories (BIO) United States $10.533B 50.56
DiaSorin S.p.A (DSRLF) Italy $7.616B 0.00
William Demant Holdings (WILYY) Denmark $7.531B 0.00
Hill-Rom Holdings (HRC) United States $7.238B 21.34
Canopy Growth (CGC) Canada $7.058B 0.00
Haemonetics (HAE) United States $5.958B 40.26
Shandong Weigao Medical Polymer (SHWGF) China $5.743B 0.00
GN STORE NORD (GNNDY) Denmark $5.276B 27.26
NuVasive (NUVA) United States $3.840B 30.24
ICU Medical (ICUI) United States $3.692B 24.07
Neogen (NEOG) United States $3.546B 59.33
GW Pharmaceuticals (GWPH) United Kingdom $3.178B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.061B 0.00
Quidel (QDEL) United States $2.984B 28.32
Aurora Cannabis (ACB) Canada $2.669B 0.00
Agios Pharmaceuticals (AGIO) United States $2.596B 0.00
National Vision Holdings (EYE) United States $2.423B 54.70
Cardiovascular Systems (CSII) United States $1.542B 0.00
InMode (INMD) Israel $1.364B 0.00
Aphria (APHA) $1.230B 0.00
AtriCure (ATRC) United States $1.218B 0.00
VAREX IMAGING (VREX) United States $1.182B 23.68
Phibro Animal Health (PAHC) United States $0.986B 18.46
NanoString Technologies (NSTG) United States $0.908B 0.00
TG Therapeutics (TGTX) United States $0.890B 0.00
Lantheus Holdings (LNTH) United States $0.803B 20.07
Eagle Pharmaceuticals (EGRX) United States $0.803B 30.76
Quanterix (QTRX) United States $0.704B 0.00
LeMaitre Vascular (LMAT) United States $0.697B 39.17
PetIQ (PETQ) United States $0.695B 16.97
Omeros (OMER) United States $0.662B 0.00
HEXO (HEXO) $0.563B 0.00
Cerus (CERS) United States $0.540B 0.00
Surmodics (SRDX) United States $0.532B 55.32
OraSure Technologies (OSUR) United States $0.485B 29.07
MacroGenics (MGNX) United States $0.474B 0.00
Owens & Minor (OMI) United States $0.445B 16.47
Organigram Holdings (OGI) Canada $0.400B 0.00
Meridian Bioscience (VIVO) United States $0.395B 13.57
Utah Medical Products (UTMD) United States $0.388B 28.08
BioLife Solutions (BLFS) United States $0.309B 125.75
Zynex (ZYXI) United States $0.293B 33.19
Bovie Medical (APYX) United States $0.273B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.265B 0.00
United Health Products (UEEC) United States $0.245B 0.00
Viemed Healthcare (VMD) United States $0.244B 25.76
Vapotherm (VAPO) United States $0.244B 0.00
Repro-Med Systems (KRMD) United States $0.239B 0.00
Liberty Health Sciences (LHSIF) Canada $0.179B 0.00
InfuSystems Holdings (INFU) United States $0.164B 824.00
Green Organic Dutchman Holdings (TGODF) Canada $0.160B 0.00
Female Health (VERU) United States $0.159B 0.00
Rockwell Medical (RMTI) United States $0.147B 0.00
MTech Acquisition (KERN) United States $0.132B 0.00
Cytosorbents (CTSO) United States $0.129B 0.00
Fonar (FONR) United States $0.127B 8.98
Chimerix (CMRX) United States $0.116B 0.00
United-Guardian (UG) United States $0.091B 22.91
Oramed Pharmaceuticals (ORMP) United States $0.090B 0.00
Chembio Diagnostics (CEMI) United States $0.076B 0.00
Nephros (NEPH) United States $0.066B 0.00
MRI Interventions (MRIC) United States $0.063B 0.00
Surface Oncology (SURF) United States $0.051B 0.00
ImmuCell (ICCC) United States $0.037B 0.00
Trinity Biotech (TRIB) Ireland $0.024B 0.00
Senestech (SNES) United States $0.016B 0.00
Valeritas Holdings (VLRX) United States $0.015B 0.00
GUARDION HEALTH (GHSI) United States $0.014B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.013B 0.00
Myomo (MYO) United States $0.008B 0.00
Capricor Therapeutics (CAPR) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.005B 0.00
Akers Biosciences Inc (AKER) United States $0.002B 0.00